We are live on !
Find out more
Linden Thomas Advisory Services Portfolio holdings
AUM
$1.26B
Turnover
7.73%
1-Year Est. Return
37.95%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+37.95%
3 Year Est. Return
+148.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.26B
AUM Growth
+$19.2M
(+1.6%)
Cap. Flow
+$30.9M
Cap. Flow % of AUM
Cap. Flow %
2.46%
Top 10 Holdings %
Top 10 Hldgs %
15.07%
Holding
569
New
27
Increased
317
Reduced
206
Closed
17
Avg Time Held
2.5
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.22M |
| 2 |
REX American Resources
REX
|
+$1.81M |
| 3 |
St. Joe Company
JOE
|
+$1.73M |
| 4 |
Cullen/Frost Bankers
CFR
|
+$1.71M |
| 5 |
Preformed Line Products
PLPC
|
+$1.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Catalyst Pharmaceutical
CPRX
|
+$5.53M |
| 2 |
Comfort Systems
FIX
|
+$3.4M |
| 3 |
Ichor Holdings
ICHR
|
+$2.62M |
| 4 |
Select Medical
SEM
|
+$2.19M |
| 5 |
La-Z-Boy
LZB
|
+$1.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.71% |
| 2 | Industrials | 13.48% |
| 3 | Healthcare | 12.55% |
| 4 | Financials | 9.46% |
| 5 | Consumer Discretionary | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Neurocrine Biosciences
NBIX
$16.9B
| $2.63M | 0.21% |
18,528
-148
| -0.8% | -$23.8K |
2022 Q4
15 quarters
|
|
152
Microchip Technology
MCHP
$33.6B
| $2.6M | 0.21% |
33,494
-185
| -0.5% | -$14.4K |
2026 Q1
2 quarters
|
|
153
Astrana Health
ASTH
$1.58B
| $2.59M | 0.21% |
72,846
+6,953
| +11% | +$274K |
2023 Q2
13 quarters
|
|
154
Safety Insurance
SAFT
$1.53B
| $2.58M | 0.21% |
24,906
+115
| +0.5% | +$11.1K |
2022 Q4
15 quarters
|
|
155
Avient
AVNT
$4.1B
| $2.57M | 0.2% |
63,823
+4,212
| +7% | +$171K |
2023 Q2
13 quarters
|
|
156
Photronics
PLAB
$1.63B
| $2.51M | 0.2% |
81,673
+402
| +0.5% | +$12K |
2023 Q2
13 quarters
|
|
157
Jones Lang LaSalle
JLL
$16.8B
| $2.49M | 0.2% |
8,164
+565
| +7% | +$196K |
2022 Q4
15 quarters
|
|
158
Aecom
ACM
$9.07B
| $2.49M | 0.2% |
42,292
+402
| +1% | +$26.8K |
2025 Q2
5 quarters
|
|
159
SPS Commerce
SPSC
$2.88B
| $2.48M | 0.2% |
30,121
-249
| -0.8% | -$18.5K |
2023 Q3
12 quarters
|
|
160
Spotify
SPOT
$126B
| $2.46M | 0.2% |
5,052
+133
| +3% | +$67.7K |
2026 Q1
2 quarters
|
|
161
Oneok
OKE
$56.6B
| $2.45M | 0.2% |
28,780
+322
| +1% | +$29.6K |
2022 Q4
15 quarters
|
|
162
Mueller Industries
MLI
$12B
| $2.45M | 0.19% |
40,473
+2,783
| +7% | +$173K |
2023 Q3
12 quarters
|
|
163
ASML
ASML
$576B
| $2.45M | 0.19% |
1,354
+340
| +34% | +$589K |
2024 Q1
10 quarters
|
|
164
Hawkins
HWKN
$3.09B
| $2.45M | 0.19% |
19,460
+1,400
| +8% | +$182K |
2023 Q2
13 quarters
|
|
165
Globalstar
GSAT
$11.2B
| $2.42M | 0.19% |
29,223
-238
| -0.8% | -$19.4K |
2023 Q2
13 quarters
|
|
166
Transcat
TRNS
$979M
| $2.41M | 0.19% |
27,203
+2,288
| +9% | +$202K |
2023 Q2
13 quarters
|
|
167
MSC Industrial Direct
MSM
$6.62B
| $2.34M | 0.19% |
18,900
+328
| +2% | +$40K |
2023 Q3
12 quarters
|
|
168
Medpace
MEDP
$18.3B
| $2.33M | 0.19% |
3,739
-27
| -0.7% | -$15.8K |
2022 Q4
15 quarters
|
|
169
Marvell Technology
MRVL
$141B
| $2.33M | 0.18% |
8,801
+20
| +0.2% | +$4.48K |
2023 Q3
12 quarters
|
|
170
Ulta Beauty
ULTA
$28.2B
| $2.31M | 0.18% |
4,230
+29
| +0.7% | +$15K |
2022 Q4
15 quarters
|
|
171
Ralph Lauren
RL
$22.8B
| $2.31M | 0.18% |
6,494
+518
| +9% | +$191K |
2022 Q4
15 quarters
|
|
172
Motorola Solutions
MSI
$87.8B
| $2.29M | 0.18% |
5,126
+129
| +3% | +$58.1K |
2024 Q2
9 quarters
|
|
173
Columbia Banking Systems
COLB
$17.1B
| $2.28M | 0.18% |
79,750
+975
| +1% | +$30.2K |
2024 Q2
9 quarters
|
|
174
CoStar Group
CSGP
$12.5B
| $2.28M | 0.18% |
83,149
+70
| +0.1% | +$2.1K |
2022 Q4
15 quarters
|
|
175
Cohu
COHU
$2.06B
| $2.28M | 0.18% |
33,421
-151
| -0.4% | -$8.19K |
2023 Q2
13 quarters
|
|
Similar funds
Linden Thomas Advisory Services's Q3 2026 Portfolio in Review
As of Q3 2026, Linden Thomas Advisory Services held 569 positions worth $1.26B, up 1.6% from $1.24B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Linden Thomas Advisory Services's Q3 2026 filing shows 27 new, 317 increased, 206 reduced and 17 closed positions. Its largest new stake was REX American Resources: 41,282 shares worth $1.79M. The largest sale was Catalyst Pharmaceutical, an estimated $5.53M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Industrials and Healthcare.
- Linden Thomas Advisory Services's largest Q3 2026 buy was REX American Resources: 41,282 shares worth $1.79M.
- Linden Thomas Advisory Services added most to Amazon in Q3 2026, an estimated $3.22M increase.
- Linden Thomas Advisory Services's biggest Q3 2026 reduction was Comfort Systems, cutting an estimated $3.4M.
- Linden Thomas Advisory Services fully exited Catalyst Pharmaceutical in Q3 2026, selling an estimated $5.53M.
- Linden Thomas Advisory Services's ten largest holdings make up 15% of its $1.26B portfolio in Q3 2026.
- Linden Thomas Advisory Services opened 27 new positions and closed 17 in Q3 2026.
- Linden Thomas Advisory Services's portfolio value rose 1.6% quarter-over-quarter to $1.26B.
Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.